| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Drug attrition during pre-clinical and clinical development: Understanding and managing drug-induced cardiotoxicity
|
Ferri, Nicola
|
|
2013
|
138 |
3 |
p. 470-484
15 p.
|
article
|
| 2 |
E-type prostanoid receptor 4 (EP4) in disease and therapy
|
Konya, Viktoria
|
|
2013
|
138 |
3 |
p. 485-502
18 p.
|
article
|
| 3 |
Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies
|
Valera, Elvira
|
|
2013
|
138 |
3 |
p. 311-322
12 p.
|
article
|
| 4 |
Monoclonal antibody-based therapies in cancer: Advances and challenges
|
Sapra, Puja
|
|
2013
|
138 |
3 |
p. 452-469
18 p.
|
article
|
| 5 |
Neuroimmune communication in hypertension and obesity: A new therapeutic angle?
|
de Kloet, Annette D.
|
|
2013
|
138 |
3 |
p. 428-440
13 p.
|
article
|
| 6 |
Polarity proteins as regulators of cell junction complexes: Implications for breast cancer
|
Bazzoun, Dana
|
|
2013
|
138 |
3 |
p. 418-427
10 p.
|
article
|
| 7 |
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
|
Csermely, Peter
|
|
2013
|
138 |
3 |
p. 333-408
76 p.
|
article
|
| 8 |
Targeting the serotonin pathway for the treatment of pulmonary arterial hypertension
|
Thomas, Matthew
|
|
2013
|
138 |
3 |
p. 409-417
9 p.
|
article
|
| 9 |
Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases
|
Li, Jing
|
|
2013
|
138 |
3 |
p. 441-451
11 p.
|
article
|
| 10 |
Type 2 ryanodine receptor: A novel therapeutic target in myocardial ischemia/reperfusion
|
Fauconnier, Jérémy
|
|
2013
|
138 |
3 |
p. 323-332
10 p.
|
article
|
Journal description